Unknown OBSERVATIONAL NCT01639365

SmartTouch Catheter in Ablation of Ventricular Tachycardia

Usefulness of the SmartTouch Catheter to Assess the Areas of Myocardial Scar in Patients With Ventricular Tachycardia

Sponsor: Biosense Webster, Inc.

Conditions Arrhythmias, Cardiac Cardiomyopathies Myocardial Infarction Tachycardia, Ventricular

Updated 7 times since 2017 Last updated: Sep 4, 2015 Started: Jul 31, 2012 Primary completion: Jan 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Arrhythmias, Cardiac and Cardiomyopathies and is currently ongoing. Biosense Webster, Inc. leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 2 earlier versions

Oct 2017 — Apr 2018 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Oct 2017 [monthly]

Active Not Recruiting NA

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biosense Webster, Inc.
Hospital Universitario Virgen de la Arrixaca

Data source: Hospital Universitario Virgen de la Arrixaca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Murcia, Spain